958 related articles for article (PubMed ID: 21679902)
41. Pattern of myocardial
Pradel S; Brun S; Victor G; Pascal P; Fournier P; Ribes D; Lavie-Badie Y; Galinier M; Carrié D; Berry I; Lairez O;
J Nucl Cardiol; 2020 Feb; 27(1):96-105. PubMed ID: 29881913
[TBL] [Abstract][Full Text] [Related]
42. Volumetric evaluation of
Watanabe S; Nakajima K; Wakabayashi H; Yoneyama H; Yoshida S; Komatsu J; Konishi T; Inaki A; Kinuya S
J Nucl Cardiol; 2022 Dec; 29(6):3102-3110. PubMed ID: 34907500
[TBL] [Abstract][Full Text] [Related]
43. Transthyretin amyloid cardiomyopathy disease burden quantified using
Watanabe S; Nakajima K; Toshima F; Wakabayashi H; Yoshida S; Yoneyama H; Komatsu J; Konishi T; Kinuya S
J Nucl Cardiol; 2023 Dec; 30(6):2721-2735. PubMed ID: 37605060
[TBL] [Abstract][Full Text] [Related]
44. Prognostic significance of strain Doppler imaging in light-chain amyloidosis.
Koyama J; Falk RH
JACC Cardiovasc Imaging; 2010 Apr; 3(4):333-42. PubMed ID: 20394893
[TBL] [Abstract][Full Text] [Related]
45. Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role.
Longhi S; Quarta CC; Milandri A; Lorenzini M; Gagliardi C; Manuzzi L; Bacchi-Reggiani ML; Leone O; Ferlini A; Russo A; Gallelli I; Rapezzi C
Amyloid; 2015; 22(3):147-55. PubMed ID: 25997105
[TBL] [Abstract][Full Text] [Related]
46. Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS).
Bhuiyan T; Helmke S; Patel AR; Ruberg FL; Packman J; Cheung K; Grogan D; Maurer MS
Circ Heart Fail; 2011 Mar; 4(2):121-8. PubMed ID: 21191093
[TBL] [Abstract][Full Text] [Related]
47. Unusual high 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid (99mTc-DPD) tracer deposition on a heart scintigraphy in a patient with AL amyloidosis: A case report.
Persia-Paulino YR; Cuevas-Perez J; Fernandez-Asensio R; Junco-Vicente A; Rozado-Castano J; Colunga S; Cigarran H; Calvo J; Laverde A; Persia O; Capin-Sampedro E
J Nucl Cardiol; 2021 Jun; 28(3):1117-1125. PubMed ID: 32333280
[TBL] [Abstract][Full Text] [Related]
48. The "Wagshurst study": p.Val40Ile transthyretin gene variant causes late-onset cardiomyopathy.
Bauer R; Dikow N; Brauer A; Kreuter M; Buss S; Evers C; Röcken C; Schnabel PA; Hinderhofer K; Ehlermann P; Katus HA; Kristen AV
Amyloid; 2014 Dec; 21(4):267-75. PubMed ID: 25291558
[TBL] [Abstract][Full Text] [Related]
49. Regression of Myocardial
Papathanasiou M; Kessler L; Bengel FM; Jakstaite AM; Kersting D; Varasteh Z; Luedike P; Carpinteiro A; Herrmann K; Rassaf T; Rischpler C
J Nucl Med; 2023 Jul; 64(7):1083-1086. PubMed ID: 37290801
[TBL] [Abstract][Full Text] [Related]
50. Diagnostic and prognostic value of Technetium-99m pyrophosphate uptake quantitation for transthyretin cardiac amyloidosis.
Miller RJH; Cadet S; Mah D; Pournazari P; Chan D; Fine NM; Berman DS; Slomka PJ
J Nucl Cardiol; 2021 Oct; 28(5):1835-1845. PubMed ID: 33689152
[TBL] [Abstract][Full Text] [Related]
51. Cardiac denervation evidenced by MIBG occurs earlier than amyloid deposits detection by diphosphonate scintigraphy in TTR mutation carriers.
Piekarski E; Chequer R; Algalarrondo V; Eliahou L; Mahida B; Vigne J; Adams D; Slama MS; Le Guludec D; Rouzet F
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1108-1118. PubMed ID: 29511839
[TBL] [Abstract][Full Text] [Related]
52. 99mTc DPD is the preferential bone tracer for diagnosis of cardiac transthyretin amyloidosis.
Rossi P; Tessonnier L; Frances Y; Mundler O; Granel B
Clin Nucl Med; 2012 Aug; 37(8):e209-10. PubMed ID: 22785530
[TBL] [Abstract][Full Text] [Related]
53. Quantitative Comparison Between Amyloid Deposition Detected by (99m)Tc-Diphosphonate Imaging and Myocardial Deformation Evaluated by Strain Echocardiography in Transthyretin-Related Cardiac Amyloidosis.
Di Bella G; Minutoli F; Piaggi P; Casale M; Mazzeo A; Zito C; Oreto G; Baldari S; Vita G; Pingitore A; Khandheria BK; Carerj S
Circ J; 2016 Aug; 80(9):1998-2003. PubMed ID: 27477961
[TBL] [Abstract][Full Text] [Related]
54. Technetium-99m-pyrophosphate imaging-based computed tomography-guided core-needle biopsy of internal oblique muscle in wild-type transthyretin cardiac amyloidosis.
Takahashi K; Hiratsuka Y; Iwamura T; Sasaki D; Yamamura N; Kitazawa S; Ueda M; Morioka H; Okura T; Enomoto D; Uemura S; Kono T; Sakaue T; Ikeda S
Amyloid; 2024 Mar; 31(1):12-21. PubMed ID: 37486102
[TBL] [Abstract][Full Text] [Related]
55. Magnetic Resonance in Transthyretin Cardiac Amyloidosis.
Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Zumbo G; Knight DS; Kotecha T; Francis R; Hutt DF; Rezk T; Rosmini S; Quarta CC; Whelan CJ; Kellman P; Gillmore JD; Moon JC; Hawkins PN; Fontana M
J Am Coll Cardiol; 2017 Jul; 70(4):466-477. PubMed ID: 28728692
[TBL] [Abstract][Full Text] [Related]
56. Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles.
Knight DS; Zumbo G; Barcella W; Steeden JA; Muthurangu V; Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Kotecha T; Francis R; Rezk T; Quarta CC; Whelan CJ; Lachmann HJ; Wechalekar AD; Gillmore JD; Moon JC; Hawkins PN; Fontana M
JACC Cardiovasc Imaging; 2019 May; 12(5):823-833. PubMed ID: 29680336
[TBL] [Abstract][Full Text] [Related]
57.
Khor YM; Cuddy SAM; Singh V; Falk RH; Di Carli MF; Dorbala S
Radiology; 2023 Feb; 306(2):e221082. PubMed ID: 36537896
[TBL] [Abstract][Full Text] [Related]
58. Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis.
Cuddy SA; Datar Y; Ovsak G; Saith S; Murphy SP; Bay CP; Haddad M; Lilleness B; Muralidhar V; Pipilas A; Vuong J; Guardino E; Maurer MS; Ruberg FL; Falk RH; Dorbala S
Circ Cardiovasc Imaging; 2022 Nov; 15(11):e014645. PubMed ID: 36378779
[TBL] [Abstract][Full Text] [Related]
59. Diagnostic value of heart-to-mediastinum ratio in
Ikoma T; Ohtani H; Ohno K; Iguchi K; Suwa K; Sawada M; Tanahashi Y; Sakamoto A; Saotome M; Ichikawa S; Goshima S; Maekawa Y
J Nucl Cardiol; 2023 Aug; 30(4):1374-1381. PubMed ID: 36547805
[TBL] [Abstract][Full Text] [Related]
60. Extracellular Volume Fraction by Computed Tomography Predicts Long-Term Prognosis Among Patients With Cardiac Amyloidosis.
Gama F; Rosmini S; Bandula S; Patel KP; Massa P; Tobon-Gomez C; Ecke K; Stroud T; Condron M; Thornton GD; Bennett JB; Wechelakar A; Gillmore JD; Whelan C; Lachmann H; Taylor SA; Pugliese F; Fontana M; Moon JC; Hawkins PN; Treibel TA
JACC Cardiovasc Imaging; 2022 Dec; 15(12):2082-2094. PubMed ID: 36274040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
